Recombinant Gluconobacter oxydans Enolase (eno)

Shipped with Ice Packs
In Stock

Description

Introduction

Gluconobacter oxydans is a bacterium known for its ability to oxidize various substrates, making it valuable in industrial biotechnology . Recombinant Gluconobacter oxydans Enolase (Eno) refers to the enolase enzyme that is produced by introducing the enolase gene into a host organism, which is then expressed to produce the enzyme in larger quantities . Enolase, a key enzyme in glycolysis and gluconeogenesis, catalyzes the reversible dehydration of 2-phosphoglycerate to phosphoenolpyruvate .

Characteristics of Gluconobacter oxydans

Gluconobacter oxydans exhibits several notable characteristics:

  • Incomplete Oxidation: It incompletely oxidizes glucose to gluconate .

  • Versatility: It can oxidize a variety of sugars, polyols, and alcohols into acids, aldehydes, and ketones, which is useful for producing valuable compounds .

  • Industrial Applications: G. oxydans is used in the production of L-ascorbic acid (vitamin C), miglitol, gluconic acid, and dihydroxyacetone .

Enolase as a Target

Enolase is considered an essential enzyme because it participates in the glycolysis/gluconeogenesis pathway . Studies have explored enolase as a target for developing antibacterial compounds . For example, 2-aminothiazoles have been shown to target enolase in Mycobacterium tuberculosis . Overexpression of Eno in M. tuberculosis resulted in resistance to 2-aminothiazoles, suggesting that enolase is a direct target of these compounds .

Enolase Overexpression

Overexpressing enolase in M. tuberculosis leads to increased resistance to 2-aminothiazoles (2-ATs) . Even a small increase in enolase production can significantly affect the viability of M. tuberculosis in the presence of 2-AT inhibitors . Conversely, reducing the amount of enolase increases the susceptibility of M. tuberculosis to 2-ATs .

Metabolic Effects of Enolase Inhibition

Inhibiting enolase activity with compounds like 2-aminothiazoles results in the accumulation of upstream intermediates in the glycolysis pathway . Metabolomic analysis of M. tuberculosis treated with 2-ATs showed a significant increase in 3-phosphoglycerate, which is consistent with enolase inhibition . Additionally, glucose levels were significantly increased in M. tuberculosis cells treated with 2-ATs, further supporting the disruption of glucose metabolism .

Application in Asymmetric Reduction

Recombinant enoate reductase from Gluconobacter oxydans can be used in the asymmetric reduction of activated alkenes . This enzyme has been heterologously expressed, purified, and characterized for this purpose . It can be used in the biotransformation of compounds like 3,5,5-trimethyl-2-cyclohexen-1,4-dione (ketoisophorone) and (E/Z)-3,7-dimethyl-2,6-octadienal (citral) . The reaction proceeds with excellent stereoselectivity (>99% ee) and absolute chemo- and regioselectivity . Only the activated C=C bond of citral is reduced by the enoate reductase, while non-activated C=C bonds and carbonyl moieties remain untouched . This strategy can be used to produce enantiomerically pure building blocks that are difficult to prepare chemically .

Table 1: Effects of Enolase Overexpression on MIC of 2-AT Compounds in M. tuberculosis

CompoundWild-Type MICEno-OE MIC (Non-Induced)Eno-OE MIC (Induced)Fold Shift (Non-Induced)Fold Shift (Induced)
IDR-0106967ValueValueValueValueValue
Other 2-ATsValueValueValueValueValue

Note: The specific MIC values would be populated based on experimental data from the study.

Table 2: Metabolomic Analysis of M. tuberculosis Treated with IDR-0106967

MetaboliteUntreated ControlDrug-TreatedChange
3-PhosphoglycerateValueValueSignificant Increase
GlucoseValueValueSignificant Increase
Other Glycolytic IntermediatesValueValueChange

Note: The specific values would be derived from metabolomic data in the cited study.

Product Specs

Form
Lyophilized powder Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates. Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. The tag type is determined during production. If a specific tag type is required, please inform us, and we will prioritize its development.
Synonyms
eno; GOX2279Enolase; EC 4.2.1.11; 2-phospho-D-glycerate hydro-lyase; 2-phosphoglycerate dehydratase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-426
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Gluconobacter oxydans (strain 621H) (Gluconobacter suboxydans)
Target Names
eno
Target Protein Sequence
MSAIVDITSR EILDSRGNPT VEVEVELSSG ARGRAAVPSG ASTGAHEAVE LRDGDKSRYG GKGVLKACSH VENDILEVLQ GAESEDQIAI DNAMIDLDGT PNKSRLGANA ILGVSLAVAK ATAEELELPL YRYVGGAYAH LLPVPMMNIV NGGEHADNPI DIQEFMIQPV GAPTVADAIR MGSEIFARLK KGLSEAGYNT NVGDEGGFAP NLKSADEALG FIAKSVEAAG YKLGEDVTFA LDCAATEFYA DGRYNLKGEG KEFDASGMIS YLEDLANRYP IVSIEDGLAE DDWEGWAELT TRLGKKLQLV GDDLFVTNPE RLRRGIKAGT GNALLVKVNQ IGTLTETLEA VETAHKAGYA CVMSHRSGET EDSVIADLAV ATNCGQIKTG SLSRSDRTAK YNQLIRIEQQ LGSAARYAGR SILKNS
Uniprot No.

Target Background

Function

Catalyzes the reversible interconversion of 2-phosphoglycerate and phosphoenolpyruvate. It plays a critical role in carbohydrate catabolism via glycolysis.

Database Links

KEGG: gox:GOX2279

STRING: 290633.GOX2279

Protein Families
Enolase family
Subcellular Location
Cytoplasm. Secreted. Cell surface.

Q&A

What is Gluconobacter oxydans and why is it significant in research?

Gluconobacter oxydans is an important Gram-negative industrial microorganism known for its extensive incomplete oxidation of sugars and alcohols. It possesses a variety of membrane-bound dehydrogenases that can partially oxidize alcohols and sugars into corresponding organic acids in the periplasmic space while obtaining energy. This organism has been used industrially since the 1930s for various bioconversion processes, including the production of vitamin C through the conversion of D-sorbitol to L-sorbose, making it an essential industrial strain for incomplete oxidation processes . Its unique metabolism and enzymatic systems make G. oxydans a valuable organism for both fundamental research and industrial applications.

What is the role of enolase in G. oxydans metabolism?

While the provided search results don't specifically detail G. oxydans enolase, this enzyme typically plays a crucial role in glycolysis. In most organisms, enolase (EC 4.2.1.11) catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in the ninth step of glycolysis. In G. oxydans, which shows exceptional characteristics like biphasic growth on glucose and incomplete oxidation of glucose to gluconate, the central carbon metabolism differs from that of many other bacteria . The organism contains both membrane-bound dehydrogenases for periplasmic oxidation and cytoplasmic oxidoreductases for intracellular metabolism, creating a complex metabolic network in which enolase likely serves as a key connecting enzyme .

How does G. oxydans differ from other bacteria in its central carbon metabolism?

G. oxydans exhibits a distinctive metabolism characterized by:

  • Rapid incomplete oxidation of sugars and alcohols in the periplasmic space

  • Lower biomass production compared to other microorganisms

  • Regioselective oxidation of many substrates

  • A unique "deposit and withdrawal" system for sugars and sugar acids

The organism oxidizes compounds in the periplasm, and the oxidized products can later be taken up and reduced in the cytoplasm through a different set of soluble oxidoreductases . This strategy allows G. oxydans to thrive in nutrient-rich environments by rapidly converting substrates into forms that are difficult for competing microorganisms to assimilate . These metabolic characteristics make G. oxydans enzymes, including potentially enolase, interesting subjects for research into novel metabolic pathways.

What are the optimal expression systems for recombinant G. oxydans enolase?

For heterologous expression of G. oxydans enzymes, E. coli expression systems have proven effective, as demonstrated with other G. oxydans enzymes such as enoate reductase . When expressing G. oxydans enzymes:

  • E. coli strains like JM109 and BL21 can be used for plasmid construction and protein expression

  • Broad-host plasmids like pBBR1MCS-5 have been successfully used with G. oxydans

  • Expression conditions typically involve culture in LB medium at 37°C with appropriate antibiotic selection

For G. oxydans-based expression, consider that the organism carries multiple endogenous plasmids, which can pose a metabolic burden. For example, G. oxydans ATCC 621H has five plasmids (163.1, 26.6, 14.6, 13.2, and 2.7 kb), while other strains like WSH-003 have fewer plasmids . This can affect the efficiency of recombinant expression and should be considered when designing expression systems.

What purification strategies are most effective for recombinant G. oxydans enzymes?

While specific purification protocols for G. oxydans enolase aren't detailed in the search results, successful purification of other G. oxydans enzymes provides guidance. For recombinant enoate reductase from G. oxydans, researchers have successfully employed heterologous expression followed by purification techniques that preserved enzymatic activity . A general purification strategy might include:

  • Cell lysis using buffer systems compatible with the enzyme's stability

  • Initial purification through affinity chromatography (if using tagged proteins)

  • Further purification by ion exchange or size exclusion chromatography

  • Activity assays to track purification efficiency

  • Storage conditions that maintain stability (often including glycerol and reducing agents)

Purification should be optimized to maintain the structural integrity and catalytic activity of the enzyme, with conditions that mimic the acidic environment preferred by G. oxydans.

How can I verify the activity of recombinant G. oxydans enolase?

Enolase activity can be measured through several established methods:

  • Spectrophotometric assays that track the formation of phosphoenolpyruvate from 2-phosphoglycerate

  • Coupled enzyme assays linking enolase activity to measurable reactions

  • Real-time RT-PCR to verify gene expression levels before protein purification

As demonstrated with other G. oxydans enzymes, real-time RT-PCR has been effectively used to confirm that genes encoding various oxidoreductases are expressed during growth on glucose, some at relatively high levels . This approach can verify that the enolase gene is transcribed before proceeding with protein purification and activity assays.

What genetic manipulation techniques are effective for G. oxydans enolase studies?

Genetic manipulation of G. oxydans has proven challenging, but several approaches have been developed:

  • Allelic replacement systems based on the sucrose lethal gene sacB encoding L-sucrase

  • Systems based on upp encoding uracil phosphoribosyl transferase

  • Integrating foreign genes into the genome to avoid plasmid-based metabolic burden

Recent advances include:

  • The development of a CRISPRi system based on the endogenous IE type CRISPR/Cas system in G. oxydans WSH-003

  • Genome editing methods based on the reverse selection marker SacB with approximately 50% editing efficiency

How does the codon usage in G. oxydans affect heterologous expression?

While not specifically addressed in the search results, codon usage is an important consideration for heterologous expression of G. oxydans genes. G. oxydans has a high G+C content, which can lead to codon usage preferences that differ from common expression hosts like E. coli. For optimal expression:

  • Consider codon optimization when expressing G. oxydans genes in heterologous hosts

  • Examine the native context of the enolase gene in relation to its expression levels

  • Be aware that G. oxydans contains multiple membrane-bound and cytoplasmic enzymes with varying expression levels that might compete for cellular resources

Understanding the genomic context of G. oxydans, with its chromosome of 2,702,173 base pairs containing 2,432 open reading frames plus five plasmids containing an additional 232 open reading frames, provides important background for expression optimization strategies .

How can I engineer G. oxydans enolase for enhanced catalytic properties?

Engineering G. oxydans enzymes for improved properties can follow these approaches:

  • Structure-based rational design, which would require structural information about G. oxydans enolase

  • Directed evolution strategies, which have been successful with other industrial enzymes

  • Site-directed mutagenesis targeting active site residues

When applying these strategies, researchers should consider:

  • The natural environment of G. oxydans (acidic conditions, typically found in flowers and fruits)

  • The interconnected nature of central carbon metabolism enzymes

  • The preservation of favorable properties such as stereoselectivity and regioselectivity that make G. oxydans enzymes valuable

How does G. oxydans enolase interact with other enzymes in central carbon metabolism?

G. oxydans has a complex set of oxidoreductases that function in different cellular compartments. The organism contains:

  • Membrane-bound dehydrogenases for periplasmic oxidation

  • Cytoplasmic oxidoreductases for intracellular metabolism

  • PQQ-dependent enzymes such as alcohol dehydrogenase, glucose dehydrogenase, and glycerol/sorbitol dehydrogenase

Enolase would function within this metabolic network, potentially in ways that differ from typical glycolytic enzymes due to G. oxydans' unique metabolism. Understanding these interactions requires a systems biology approach integrating proteomics, metabolomics, and enzyme kinetics.

What are the kinetic parameters of G. oxydans enolase compared to enolases from other organisms?

While specific kinetic parameters for G. oxydans enolase aren't provided in the search results, the approach used for characterizing other G. oxydans enzymes can be applied. For the recombinant enoate reductase from G. oxydans, researchers determined kinetic properties and then focused on applications in biotransformation . A similar methodological approach for enolase would include:

  • Determination of substrate specificity

  • Measurement of Km, Vmax, and kcat values

  • Evaluation of pH and temperature optima

  • Assessment of cofactor requirements

  • Comparative analysis with enolases from model organisms

This characterization would provide insight into how G. oxydans enolase has adapted to function within the organism's unique metabolism.

Can G. oxydans enolase be used in multi-enzyme cascade reactions for biocatalysis?

Based on the successful application of other G. oxydans enzymes in biocatalysis, enolase could potentially be integrated into enzyme cascades. The enoate reductase from G. oxydans has demonstrated excellent stereoselectivity (>99% ee) and absolute chemo- and regioselectivity in the reduction of specific bonds . For designing multi-enzyme cascades involving G. oxydans enolase:

  • Consider the compatibility of reaction conditions between cascade components

  • Evaluate the potential for substrate channeling between enzymes

  • Assess the stability of the enzyme in the presence of other reaction components

  • Determine whether immobilization strategies might enhance performance

The unique metabolic capabilities of G. oxydans suggest that its enzymes, including enolase, might offer advantages in specific biocatalytic applications that benefit from their natural adaptation to incomplete oxidation pathways.

What are the major challenges in working with recombinant G. oxydans enolase?

Several challenges may arise when working with G. oxydans enzymes:

  • Expression challenges due to the organism's unique codon usage and metabolism

  • Difficulties in genetic manipulation as evidenced by limited success with CRISPR systems

  • The potential need for specific cofactors or conditions for optimal enzyme activity

  • Limited structural information compared to model organisms

These challenges reflect the broader difficulties in working with non-model organisms like G. oxydans, where genetic tools and background information are more limited compared to organisms like E. coli or S. cerevisiae.

How might G. oxydans enolase contribute to understanding the organism's unique metabolism?

Study of G. oxydans enolase could provide insights into:

  • Adaptations of central carbon metabolism in organisms specialized for incomplete oxidation

  • The role of glycolytic enzymes in an organism that prioritizes periplasmic oxidation

  • Evolutionary adaptations of enolase in acidophilic environments

The biphasic growth on glucose and incomplete oxidation patterns observed in G. oxydans suggest that central carbon metabolism enzymes like enolase may have unique regulatory or kinetic properties that contribute to these phenotypes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.